Lineage Cell Therapeutics, Inc. (LCTX) Revenue by Year
Lineage Cell Therapeutics, Inc. generated $14.6M in revenue in fiscal year 2025. This represents an increase of 53.2% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $13.1M in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Lineage Cell Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
LCTX Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.1M | $14.6M+53.2% | $9.5M+6.2% | $8.9M-39.2% | $14.7M+238.7% | $4.3M+137.7% | $1.8M-48.1% | $3.5M-29.5% | $5.0M+44.2% | $3.5M-41.6% | $5.9M-15.8% | $7.0M+34.2% | $5.2M+18.3% | $4.4M+13.2% | $3.9M-11.7% | $4.4M |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
LCTX Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Lineage Cell Therapeutics, Inc. financials
Frequently Asked Questions
What was Lineage Cell Therapeutics, Inc.'s revenue in fiscal year 2025?
Lineage Cell Therapeutics, Inc. generated $14.6M in revenue in fiscal year 2025.
How fast is Lineage Cell Therapeutics, Inc.'s revenue growing?
Lineage Cell Therapeutics, Inc. (LCTX) revenue rose by 53.2% year over year, from $9.5M to $14.6M in fiscal year 2025.
What is Lineage Cell Therapeutics, Inc.'s revenue over the last twelve months?
Lineage Cell Therapeutics, Inc. (LCTX) reported $13.1M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Lineage Cell Therapeutics, Inc.'s revenue changed over the years?
Across the 15 fiscal years this page covers, Lineage Cell Therapeutics, Inc. (LCTX) revenue went from $4.4M in fiscal year 2011 to $14.6M in fiscal year 2025.
What was Lineage Cell Therapeutics, Inc.'s revenue in the most recent quarter?
Lineage Cell Therapeutics, Inc. (LCTX) reported $1.1M in revenue in Q2 2026. This represents a decrease of 61.3% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Lineage Cell Therapeutics, Inc. (LCTX) reported on that line in every period on record.